FDA DEVICE FACTS
MOSES Raydar™
Boston Scientific Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The MOSES Raydar system with delivery fibers and accessories are indicated for use in the performance of specific surgical applications in Urology as follows:
• Endoscopic transurethral incision of the prostate (TUIP), bladder neck incision of the prostate (BNI), holmium laser ablation of the prostate (HoLAP), holmium laser enucleation of the prostate (HoLEP), hemostasis, vaporization, and excision for treatment of benign prostatic hyperplasia (BPH).
• Endoscopic urological surgery (ablation, vaporization, incision, excision, and coagulation of soft tissue) including treatment of: o Bladder o Bladder, urethral and ureteral tumors o Ureteral strictures
• Urinary Lithotripsy including: o Endoscopic fragmentation of urinary (urethral, ureteral, bladder and renal) calculi, including cystine, calcium oxalate, monohydrate, and calcium oxalate dihydrate stones. Prescription Use.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。